AOZ/BSA is an antigen-adjuvant conjugate of AOZ and bovine serum albumin (BSA). Conjugating the antigen with a protein adjuvant can enhance the production of antigen-specific antibodies in vaccine models. The conjugate does not affect protein folding or alter major epitopes, and it can enhance cross-presentation and the production of antigen-specific T cells.